Medroxyprogesterone Acetate: Patient Information for Australia
Basic Product Information
| International Nonproprietary Name (INN) | Medroxyprogesterone Acetate |
|---|---|
| Australian Brand Names | Provera®, Depo-Provera®, Depo-Ralovera®, Ralovera® |
| ATC Code | G03AC06 |
| Available Forms & Strengths |
|
| Manufacturers | Pfizer Australia, Aspen Pharmacare Australia, and various generic manufacturers |
| Prescription Status | Prescription Only Medicine (Schedule 4, S4) |
Mechanism of Action
For Patients: Medroxyprogesterone acts like the hormone progesterone, which is naturally produced by your ovaries. It is commonly used to help manage menstrual problems, provide contraception (birth control), and assist in hormone replacement therapy.
For Healthcare Professionals: Medroxyprogesterone acetate is a synthetic progestogen structurally related to 17α-hydroxyprogesterone. It suppresses gonadotropin production by negative feedback at the hypothalamic-pituitary axis, alters the endometrial lining, thickens cervical mucus, and prevents follicular maturation.
Pharmacokinetics
- Absorption: Tablets are absorbed from the gastrointestinal tract; injections offer slow, sustained absorption over 12–14 weeks.
- Distribution: Widely distributed, binds to plasma proteins.
- Metabolism: Rapidly hepatic; metabolites are largely inactive.
- Elimination: Excreted via urine (renal clearance); minimal biliary excretion.
- Duration of Action: Oral: Dose-dependent (hours to days). IM: 12–14 weeks (depot format).
Use in Everyday Life & Best Practices (Australian Context)
Medroxyprogesterone is widely prescribed in Australia as a contraceptive, a component of hormone replacement therapy, and for various women’s health issues. It’s available as daily tablets or long-acting injections administered by a nurse, GP, or at a sexual health clinic. Always take it exactly as prescribed.
- Oral tablets: Usually taken once daily for 5–14 days per month, depending on the reason for use.
- Depo injection (IM): Given every 12 weeks. Ensure timely follow-up appointments to maintain efficacy.
In Australia, community pharmacies dispense the medication; injections are usually performed at medical practices or sexual health centres. If you miss a dose of the tablet, take it as soon as you remember (unless nearly time for the next dose). For missed injections, contact your healthcare provider promptly.
Dosing: Morning vs Evening
- Morning dosing: May reduce insomnia or odd dreams sometimes associated with hormone therapy; easier to establish a routine with breakfast.
- Evening dosing: Preferred by some to minimise daytime side effects such as nausea or headache.
- Best practice: Take oral doses at the same time every day for consistency. Choose a time that best fits your lifestyle; consistency is more important than specific time of day.
Taking with Food or an Empty Stomach
- No significant difference has been shown in absorption whether taken with or without food.
- If you experience stomach upset, you may prefer to take your tablet with a meal or light snack (typical English breakfast or meal choices are acceptable).
- Avoid high-fat meals immediately prior to dosing if you have any digestive concerns.
Interaction Warnings
| Interaction | Caution/Advice |
|---|---|
| Other hormonal therapies | Increased risk of side effects; consult your GP or specialist. |
| Enzyme inducers (e.g., some anticonvulsants: carbamazepine, phenytoin) | May reduce medroxyprogesterone effectiveness. Regular monitoring and dose adjustments may be needed. |
| Herbal medicines (e.g., St. John’s Wort) | Can lower blood levels of medroxyprogesterone, making it less effective. |
| Alcohol | None significant, but limit excessive consumption for overall health. Alcohol may worsen some side effects (e.g., dizziness). |
| Anticoagulants | Rarely, may interfere with blood clotting; seek advice. |
| Food | No known clinically significant food interactions. |
Always seek advice from your pharmacist or GP before starting new medicines or supplements.
Indications
| Indication | Comments |
|---|---|
| Official (TGA-approved): | |
| Secondary amenorrhoea | Absence of menstrual periods in adults and adolescents. |
| Dysfunctional uterine bleeding | Unusual or heavy menstrual bleeding not caused by organic disease. |
| Contraception (Depo injection) | Long-acting, reversible birth control for women of reproductive age. |
| Add-back therapy in endometriosis and HRT | Part of hormone replacement regimens for menopause or gender-affirming care. |
| Carcinoma of endometrium/renal cell carcinoma | Adjunctive therapy; specialist use in oncology. |
| Off-label: | |
| Delayed puberty | Rarely used under paediatric endocrinologist guidance. |
| Suppression of menstruation for medical/social reasons | Common in individuals with disabilities or for menstrual management (e.g., travel, events). |
Dosing According to Clinical Indication
| Indication | Adults | Paediatric (Specialist Advice Only) | Elderly |
|---|---|---|---|
| Secondary amenorrhoea | 5–10 mg orally daily for 5–10 days per cycle | Not routinely used | As per adult dosing; adjust for comorbidities |
| Dysfunctional uterine bleeding | 5–10 mg orally daily for 5–10 days | Rarely used; only under paediatrician | As per adult dosing |
| Contraception (Depo IM) | 150 mg IM every 12 weeks | Adolescents: 150 mg IM every 12 weeks (individual risk assessment) | Not commonly prescribed |
| Endometriosis/HRT | 5–10 mg orally as part of HRT regimens, or as prescribed; or IM depot dosing | Specialist use only | Close monitoring required |
| Cancer indications | 100–500 mg orally/day or 400–1000 mg IM weekly (specialist oncology use) | Specialist paediatric oncology only | As per adult dosing, consider comorbidities |
Safety Profile & Side Effects
Most side effects are mild and many patients do not experience any. Seek medical attention if you have severe or persistent symptoms.
- Common:
- Weight gain
- Irregular periods or spotting
- Headache
- Mood changes or low mood
- Abdominal pain, bloating
- Breast tenderness
- Delayed return of fertility after stopping injections
- Uncommon/Rare:
- Blood clots (deep vein thrombosis or pulmonary embolism)
- Loss of bone mineral density (injection form, with long-term use)
- Rash or allergic reactions
- Visual changes
- Severe depression or mood disturbances
- Warnings:
- Not suitable during pregnancy
- Discuss with your GP if you have, or have had, a history of breast cancer, liver disease, or heart/blood vessel problems
- Injection form may reduce bone density; calcium and vitamin D intake should be optimised (NHS and Osteoporosis Australia guidance)
Guidelines for Proper Use: Advice from Pharmacists & Doctors in Australia
- Always take this medication exactly as directed by your doctor.
- If using the injection, schedule your next dose promptly to maintain contraceptive effect.
- Carry a written list of your current medications to share with your healthcare provider.
- Have regular GP reviews and discuss any side effects at appointments.
- Maintain adequate dietary calcium (e.g., low-fat dairy, leafy greens, alternatives) and vitamin D, especially if on long-term injections.
- Inform your doctor of any significant changes in mood or mental health.
Alternative Treatment Options
- Combined oral contraceptives (COCs; "the pill")
Pros: Menstrual control, acne benefit, rapid return of fertility.
Cons: Daily dosing required, some VTE risk. - Subdermal implants (e.g., etonogestrel, Implanon NXT®)
Pros: Long-acting (3 years), highly effective.
Cons: Requires minor procedure for insertion/removal, may cause irregular bleeding. - IUD (intrauterine device; hormonal or copper)
Pros: Long-term (5–10 years), highly effective, low maintenance.
Cons: Insertion discomfort, initial irregular bleeding. - Natural progesterones (micronised progesterone)
Pros: Lower risk of adverse metabolic effects.
Cons: Must be used in standard HRT regimens, not contraceptive. - Other agents such as norethisterone or levonorgestrel for specific uses.
Legal, Registration, & Reimbursement Status in Australia
- Therapeutic Goods Administration (TGA): Medroxyprogesterone Acetate is registered on the Australian Register of Therapeutic Goods (ARTG).
- Pharmaceutical Benefits Scheme (PBS): Subsidised for specific indications (e.g., contraception, endometriosis, some cancer indications).
- Legal status: Schedule 4 (S4) prescription medicine—only available via an Australian Prescription.
- Prescribed by GPs, specialists (e.g., gynaecologists, endocrinologists, oncologists), and nurse practitioners where appropriate.
- Pharmacist may dispense repeats as specified on the script; see your GP for ongoing review.
Latest Research & Clinical Guidance (2022–2025)
- Australian and international consensus agrees on monitoring bone density for women on long-term depot injections, particularly under age 25 (see: RANZCOG, Osteoporosis Australia 2022–2024 briefings).
- Guidelines from NICE (UK, 2024), RCOG (UK), and ACOG (USA) support use of medroxyprogesterone as an effective and safe contraceptive and in endometrial protection for HRT.
- Recent Australian PBS reviews (2022–2025) affirm broad subsidy for contraception and selected HRT uses.
- Emerging reports highlight need for careful mental health monitoring, particularly for adolescents and those with past history of depression or self-harm.
- Latest studies (Lancet, MJA, 2023–2024) reinforce no increased breast cancer risk for short-term use; long-term use in younger women should be individualised.
Availability and Delivery
- Readily available in all major Australian cities and regional/rural areas.
- Most community pharmacies stock common tablet doses and injection forms (on order if not immediately available).
- Injections administered at GP practices, sexual health, women’s health, and some Aboriginal Medical Services.
| Product/Form | Popular Pack Sizes | Indicative PBS Price (AUD)* | Delivery to Major Cities |
|---|---|---|---|
| Tablets | 30, 90 | $6.70 (PBS concessional); $27.00–$35.00 (private) | 1–2 days (Melbourne, Sydney, Brisbane, Adelaide, Perth) |
| Depo injection (IM) | 1 x 150 mg/mL | $6.70 (PBS concessional); ~$38.00 (private) | 1–2 days metropolitan, 3–4 days rural/remote |
*Indicative only. Actual price may vary; check at your local pharmacy or PBS Online.
Frequently Asked Questions (FAQ)
- Is Medroxyprogesterone safe for long-term use?
For most women and indications, long-term use is safe when monitored by a doctor. Regular reviews are needed to check bone health (especially with depo injections), mental wellbeing, and menstrual patterns. - How quickly does it work?
For birth control, protection starts within 24 hours if the injection is given in the first 5 days of your cycle. For menstrual problems, improvement is usually seen after one cycle. - Will it affect my fertility?
Fertility generally returns after stopping; injectables may take several months longer (sometimes up to one year) for periods and fertility to return. - Can I take it if I am breastfeeding?
Yes, Depo-Provera injection is considered safe during breastfeeding and does not affect breast milk supply. - What should I do if I miss a dose?
Take a missed tablet dose as soon as you remember (unless nearly time for the next dose). If you miss an injection, arrange another as quickly as possible and use extra contraception in the meantime.
For more advice about Medroxyprogesterone prepared for Australian patients, consult your pharmacist, GP, or women’s health clinic. Always follow local clinical guidelines and discuss any concerns about your medicines with a registered healthcare professional.

